Tang Chun, Wang Xuehui, Ji Changle, Zheng Wenfang, Yu Yunhe, Deng Xiaochong, Zhou Xiqian, Fang Lin
Clinical Medical College of Shanghai Tenth People's Hospital, Nanjing Medical University, Nanjing, China.
Department of Thyroid and Breast Surgery, Taizhou Fourth People's Hospital, Taizhou, China.
Front Oncol. 2021 Apr 12;11:645682. doi: 10.3389/fonc.2021.645682. eCollection 2021.
In this study, we demonstrated that miR-640 is significantly downregulated in breast cancer (BC) tissues and cell lines. Overexpression of miR-640 inhibited the proliferation and migration of BC and , while depletion of miR-640 exhibited the opposite effect. Importantly, miR-640 could directly target Wnt7b, thereby regulating Wnt/β-catenin signaling pathway in BC. In conclusion, miR-640/Wnt7b suppresses BC cells tumorigenesis Wnt/β-catenin signaling pathway, which might be novel targets for BC targeted therapy.
在本研究中,我们证明了miR-640在乳腺癌(BC)组织和细胞系中显著下调。miR-640的过表达抑制了BC的增殖和迁移,而miR-640的缺失则表现出相反的效果。重要的是,miR-640可以直接靶向Wnt7b,从而调节BC中的Wnt/β-连环蛋白信号通路。总之,miR-640/Wnt7b通过Wnt/β-连环蛋白信号通路抑制BC细胞的肿瘤发生,这可能是BC靶向治疗的新靶点。